310 related articles for article (PubMed ID: 28994249)
1. Molecular pathways of oestrogen receptors and β-adrenergic receptors in cardiac cells: Recognition of their similarities, interactions and therapeutic value.
Machuki JO; Zhang HY; Harding SE; Sun H
Acta Physiol (Oxf); 2018 Feb; 222(2):. PubMed ID: 28994249
[TBL] [Abstract][Full Text] [Related]
2. G protein-coupled estrogen receptor (GPER)/GPR30 forms a complex with the β
Tutzauer J; Serafin DS; Schmidt T; Olde B; Caron KM; Leeb-Lundberg LMF
Arch Biochem Biophys; 2024 Feb; 752():109882. PubMed ID: 38211639
[TBL] [Abstract][Full Text] [Related]
3. Dynamic regulation of phosphoinositide 3-kinase-gamma activity and beta-adrenergic receptor trafficking in end-stage human heart failure.
Perrino C; Schroder JN; Lima B; Villamizar N; Nienaber JJ; Milano CA; Naga Prasad SV
Circulation; 2007 Nov; 116(22):2571-9. PubMed ID: 17998459
[TBL] [Abstract][Full Text] [Related]
4. Raf kinase inhibitor protein: lessons of a better way for β-adrenergic receptor activation in the heart.
Lorenz K; Rosner MR; Brand T; Schmitt JP
J Physiol; 2017 Jun; 595(12):4073-4087. PubMed ID: 28444807
[TBL] [Abstract][Full Text] [Related]
5. Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo.
Barki-Harrington L; Luttrell LM; Rockman HA
Circulation; 2003 Sep; 108(13):1611-8. PubMed ID: 12963634
[TBL] [Abstract][Full Text] [Related]
6. Localization of estrogen receptor ERα, ERβ and GPR30 on myenteric neurons of the gastrointestinal tract and their role in motility.
Liu JYH; Lin G; Fang M; Rudd JA
Gen Comp Endocrinol; 2019 Feb; 272():63-75. PubMed ID: 30502347
[TBL] [Abstract][Full Text] [Related]
7. Adrenergic Receptors in Individual Ventricular Myocytes: The Beta-1 and Alpha-1B Are in All Cells, the Alpha-1A Is in a Subpopulation, and the Beta-2 and Beta-3 Are Mostly Absent.
Myagmar BE; Flynn JM; Cowley PM; Swigart PM; Montgomery MD; Thai K; Nair D; Gupta R; Deng DX; Hosoda C; Melov S; Baker AJ; Simpson PC
Circ Res; 2017 Mar; 120(7):1103-1115. PubMed ID: 28219977
[TBL] [Abstract][Full Text] [Related]
8. The beta-adrenergic receptors.
Wallukat G
Herz; 2002 Nov; 27(7):683-90. PubMed ID: 12439640
[TBL] [Abstract][Full Text] [Related]
9. A novel signaling pathway for beta-adrenergic receptor-mediated activation of phosphoinositide 3-kinase in H9c2 cardiomyocytes.
Yano N; Ianus V; Zhao TC; Tseng A; Padbury JF; Tseng YT
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H385-93. PubMed ID: 17369456
[TBL] [Abstract][Full Text] [Related]
10. Oestrogen changed cardiomyocyte contraction and beta-adrenoceptor expression in rat hearts subjected to ischaemia-reperfusion.
Wu Q; Zhao Z; Sun H; Hao YL; Yan CD; Gu SL
Exp Physiol; 2008 Sep; 93(9):1034-43. PubMed ID: 18469068
[TBL] [Abstract][Full Text] [Related]
11. A new regulation of IL-6 production in adult cardiomyocytes by beta-adrenergic and IL-1 beta receptors and induction of cellular hypertrophy by IL-6 trans-signalling.
Szabo-Fresnais N; Lefebvre F; Germain A; Fischmeister R; Pomérance M
Cell Signal; 2010 Jul; 22(7):1143-52. PubMed ID: 20227492
[TBL] [Abstract][Full Text] [Related]
12. Trafficking of β-Adrenergic Receptors: Implications in Intracellular Receptor Signaling.
Fu Q; Xiang YK
Prog Mol Biol Transl Sci; 2015; 132():151-88. PubMed ID: 26055058
[TBL] [Abstract][Full Text] [Related]
13. Biased agonism at β-adrenergic receptors.
Ippolito M; Benovic JL
Cell Signal; 2021 Apr; 80():109905. PubMed ID: 33385503
[TBL] [Abstract][Full Text] [Related]
14. The control of cardiomyocyte apoptosis via the beta-adrenergic signaling pathways.
Communal C; Colucci WS
Arch Mal Coeur Vaiss; 2005 Mar; 98(3):236-41. PubMed ID: 15816327
[TBL] [Abstract][Full Text] [Related]
15. Cardiomyocyte PKA Ablation Enhances Basal Contractility While Eliminates Cardiac β-Adrenergic Response Without Adverse Effects on the Heart.
Zhang Y; Wang WE; Zhang X; Li Y; Chen B; Liu C; Ai X; Zhang X; Tian Y; Zhang C; Tang M; Szeto C; Hua X; Xie M; Zeng C; Wu Y; Zhou L; Zhu W; Yu D; Houser SR; Chen X
Circ Res; 2019 Jun; 124(12):1760-1777. PubMed ID: 30982412
[TBL] [Abstract][Full Text] [Related]
16. Estrogen regulation of cardiac cAMP-L-type Ca
Machuki JO; Zhang HY; Geng J; Fu L; Adzika GK; Wu L; Shang W; Wu J; Kexue L; Zhao Z; Sun H
Cell Commun Signal; 2019 Apr; 17(1):34. PubMed ID: 30987657
[TBL] [Abstract][Full Text] [Related]
17. Oestrogen Receptor β Activation Protects Against Myocardial Infarction via Notch1 Signalling.
Du M; Shan J; Feng A; Schmull S; Gu J; Xue S
Cardiovasc Drugs Ther; 2020 Apr; 34(2):165-178. PubMed ID: 32157565
[TBL] [Abstract][Full Text] [Related]
18. β-Adrenergic induced SR Ca
Pereira L; Bare DJ; Galice S; Shannon TR; Bers DM
J Mol Cell Cardiol; 2017 Jul; 108():8-16. PubMed ID: 28476660
[TBL] [Abstract][Full Text] [Related]
19. Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression.
Perrino C; Naga Prasad SV; Patel M; Wolf MJ; Rockman HA
J Am Coll Cardiol; 2005 Jun; 45(11):1862-70. PubMed ID: 15936620
[TBL] [Abstract][Full Text] [Related]
20. The role of β-adrenergic receptors in the cardioprotective effects of beta-preconditioning (βPC).
Salie R; Moolman JA; Lochner A
Cardiovasc Drugs Ther; 2011 Feb; 25(1):31-46. PubMed ID: 21225332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
